Table 4.
Clinical characteristics of patients with high-grade pancreatic precancerous lesions
| Age/sex | Location | LGRFLGRS (points) | HGRFHGRS (points) | Image findings | ||
|---|---|---|---|---|---|---|
|
| ||||||
| MPD dilation (mm) | Cyst or IPMN | Histological diagnosis | ||||
| 58/male | Body | Alcohol, smoking, obesity 3 | Cyst 1 | 2.0 | (−) | High-grade PanIN |
| 71/female | Tail | Alcohol, abdominal pain 2 | MPD dilation 1 | 10.0 | (+) | High-grade PanIN |
| 73/male | Tail | DM, alcohol, abdominal pain 3 | None | 3.0 | (+) | High-grade PanIN |
| 70/male | Tail | DM, alcohol, smoking 3 | New-onset DM 1 | 4.0 | (+) | High-grade PanIN |
| 62/male | Head | Alcohol, smoking, pancreatic enzyme 3 | None | 4.5 | (−) | High-grade PanIN |
| 72/female | Body | Obesity 1 | Cyst 1 | 3.0 | (+) | High-grade PanIN |
| 72/male | Body | Family history 1 | Cyst 1 | 2.5 | (+) | High-grade PanIN |
| 66/male | Head | Smoking, abdominal pain, pancreatic enzyme 3 | IPMN 1 | 9.0 | (+) | IPMN with high-grade dysplasia |
| 82/male | Body | Family history, alcohol, obesity 3 | IPMN 1 | 4.5 | (+) | IPMN with high-grade dysplasia |
| 78/male | Body | DM, alcohol 2P | MPD dilation 1P | 10 | (+) | IPMN with high-grade dysplasia |
DM: Diabetes mellitus; HGRF: High-grade risk factor; HGRS: High-grade risk score; IPMN: Intraductal papillary mucinous neoplasm; LGRF: Low-grade risk factor; LGRS: Low-grade risk score; MN: Mural nodule; MPD: Main pancreatic duct; PanIN: Pancreatic intraepithelial neoplasia